luseogliflozin trade name lusefi pharmaceutical drug inhibitor used treatment type diabetes approved use japan metaanalysis involving data randomized controlled trials patients dutta et al demonstrated good glycaemic efficacy mean glycated hemoglobin reduction mean fasting glucose reduction safety luseogliflozin compared placebo additional benefits include significant reduction systolic blood pressure mm hg serum triglycerides uric acid alanine aminotransferase iul compared placebo highlighting beneficial impact different aspects metabolic syndrome drug article relating gastrointestinal system stub help wikipedia expanding httpsenwikipediaorgwikiluseogliflozin